Press Releases

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) issued the following statement after the Committee voted to advance 12 pieces of legislation to the full House of Representatives: 

"I am extremely proud of the legislation passed by the Judiciary Committee during this markup. The legislation we advanced will combat the sale of counterfeit products online, limit race-based hair discrimination, and help lower prescription drug costs by taking on certain anticompetitive practices employed by large pharmaceutical companies. I am particularly pleased that my legislation, the MORE Act, which will decriminalize marijuana federally and invest in communities that have been disproportionately harmed by the War on Drugs, was passed with bipartisan support. I thank all the Members for their work, and I urge passage of these bills by the full House of Representatives."

The Committee favorably reported the following bills: 

H.R. 5374, the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act:

The SHOP SAFE Act, introduced by Chairman Nadler, IP Subcommittee Chairman Hank Johnson (D-GA), IP Subcommittee Ranking Member Darrell Issa (R-CA), and Representative Ben Cline (R-VA), places greater responsibility on online platforms to help police counterfeit products sold by third parties on their platforms by incentivizing them to implement certain best practices designed to keep counterfeit products off these marketplaces if the health and safety of consumers is implicated. The bill was passed by a vote of 30-8. 

H.R. 2883, the Stop Stalling Access to Affordable Medications Act: 

The Stop Stalling Access to Affordable Medications Act, introduced by Representative Hakeem Jeffries (D-NY) and Antitrust Subcommittee Ranking Member Ken Buck (R-CO), prohibits the abuse of citizen petitions by branded-drug companies to keep lower-cost generic competitors off the market. The bill was passed by a vote of 31-9. 

H.R. 2891, Preserve Access to Affordable Generics and Biosimilars Act: 

The Preserve Access to Affordable Generics and Biosimilars Act, introduced by Chairman Nadler and Antitrust Subcommittee Ranking Member Buck, prohibits anti-competitive settlements, also called pay-for-delay agreements, that block access to affordable prescription drugs. The bill was passed by a vote of 28-13. 

H.R. 2873, the Affordable Prescriptions for Patients Through Promoting Competition Act of 2021:

The Affordable Prescriptions for Patients Through Promoting Competition Act, introduced by Antitrust Subcommittee Chairman David N. Cicilline (D-RI) and Antitrust Subcommittee Ranking Member Buck, ends product hopping, an abusive tactic that involves making a trivial change to a product that is facing the end of patent exclusivity—such as a change to its dosage or delivery mechanism—to avoid generic competition. The bill was passed by a vote of 27-16. 

H.R. 2884, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act:

The Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act, introduced by IP Subcommittee Chairman Johnson and IP Subcommittee Ranking Member Issa, helps lower prescription drug costs by limiting the number patents that a brand-name manufacturer can assert in litigation, which forces the manufacturer to focus on its key patents with the goal of streamlining the resolution of disputes with companies that want to sell biosimilar versions of that biologic. The bill was passed by a voice vote. 

H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2021: 

The MORE Act, introduced by Chairman Nadler and Representatives Barbara Lee (D-CA), Earl Blumenauer (D-OR), Nydia Velazquez (D-NY), Sheila Jackson Lee (D-TX), and Hakeem Jeffries (D-NY), removes marijuana from the list of federally controlled substances, addresses the needs of communities that have been seriously impacted by the War on Drugs, and provides for the expungement of Federal marijuana convictions and arrests. The bill was passed by a vote of 26-15. 

H.R. 2116, the Creating a Respectful and Open World for Natural Hair Act of 2021:

The CROWN Act, introduced by Representative Bonnie Watson Coleman (D-NJ), explicitly prohibits discrimination on the basis of hair texture or hairstyles commonly associated with a particular race or national origin in areas of the law where discrimination on the basis of race or national origin is already prohibited. The bill was passed by a vote of 23-15.

H.R. 187, For the relief of Victoria Galindo Lopez

This legislation, introduced by Representative Julia Brownley (D-CA), provides for the relief of Victoria Galindo Lopez. The bill was passed by unanimous consent.

H.R. 680, For the relief of Arpita Kurdekar, Girish Kurdekar, and Vandana Kurdekar

This legislation, introduced by Representative Ann Kuster (D-NH), provides for the relief of Arpita Kurdekar, Girish Kurdekar, and Vandana Kurdekar. The bill was passed by unanimous consent.

H.R. 681,  For the relief of Rebecca Trimble

This legislation, introduced by Representative Don Young (R-AK), provides for the relief of Rebecca Trimble. The bill was passed by unanimous consent.

H.R. 739,  For the relief of Median El-Moustrah

This legislation, introduced by Representative Rashida Tlaib (D-MI), provides for the relief of Median El-Moustrah. The bill was passed by unanimous consent.

H.R. 785 For the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, and Karla Maria Barrera De Bueso

This legislation, introduced by Representative Mark DeSaulnier (D-CA), provides for the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, and Karla Maria Barrera De Bueso. The bill was passed by unanimous consent.